Elizabeth A M Feijen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Elizabeth A M Feijen

Showing results (1-10 of 33) with videos related to

Pageof 4

Sort By:

Journal of Molecular Medicine (Berlin, Germany)|May 30, 2021

Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysisJan M Leerink, Mabel van de Ruit, Elizabeth A M Feijen, et al.

Human Reproduction (Oxford, England)|January 28, 2023

Childhood cancer and hematological disorders negatively affect spermatogonial quantity at diagnosis: a retrospective study of a male fertility preservation cohortIeva Masliukaite, Elissavet Ntemou, Elizabeth A M Feijen, et al.

BMC Cancer|September 14, 2023

Acute and early-onset cardiotoxicity in children and adolescents with cancer: a systematic reviewTheodorus W Kouwenberg, Elvira C van Dalen, Elizabeth A M Feijen, et al.

Pediatric Blood & Cancer|April 28, 2022

Electrocardiographic abnormalities in childhood cancer survivors treated with cardiotoxic therapy: a systematic reviewEsmée C de Baat, Elizabeth A M Feijen, Jorrit B van Niekerk, et al.

JACC. Cardiooncology|August 16, 2021

Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood CancerJan M Leerink, Helena J H van der Pal, Leontien C M Kremer, et al.

Cancer Medicine|May 3, 2026

Early Detection of Acute and Early-Onset Cancer Therapy-Related Cardiac Dysfunction in Children With Cancer Using a Multiparametric Approach: Methodological Aspects of the EARLY StudyTheodorus W Kouwenberg, Heynric B Grotenhuis, Leontien C M Kremer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015

Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood CancerElizabeth A M Feijen, Wendy M Leisenring, Kayla L Stratton, et al.

Journal of Cancer Survivorship : Research and Practice|March 27, 2021

Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic reviewRemy Merkx, Jan M Leerink, Esmée C de Baat, et al.

European Journal of Heart Failure|August 19, 2020

The cancer patient and cardiologyJosé Luis Zamorano, Christer Gottfridsson, Riccardo Asteggiano, et al.

JACC. Cardiooncology|August 16, 2021

Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: <i>JACC CardioOncology</i> State-of-the-Art ReviewJan M Leerink, Esmée C de Baat, Elizabeth A M Feijen, et al.

Pageof 4

Search research articles

Showing results (1-10 of 33) with videos related to

Sort By:

Pageof 4

Journal of Molecular Medicine (Berlin, Germany)|May 30, 2021

Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysisJan M Leerink, Mabel van de Ruit, Elizabeth A M Feijen, et al.

Human Reproduction (Oxford, England)|January 28, 2023

Childhood cancer and hematological disorders negatively affect spermatogonial quantity at diagnosis: a retrospective study of a male fertility preservation cohortIeva Masliukaite, Elissavet Ntemou, Elizabeth A M Feijen, et al.

BMC Cancer|September 14, 2023

Acute and early-onset cardiotoxicity in children and adolescents with cancer: a systematic reviewTheodorus W Kouwenberg, Elvira C van Dalen, Elizabeth A M Feijen, et al.

Pediatric Blood & Cancer|April 28, 2022

Electrocardiographic abnormalities in childhood cancer survivors treated with cardiotoxic therapy: a systematic reviewEsmée C de Baat, Elizabeth A M Feijen, Jorrit B van Niekerk, et al.

JACC. Cardiooncology|August 16, 2021

Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood CancerJan M Leerink, Helena J H van der Pal, Leontien C M Kremer, et al.

Cancer Medicine|May 3, 2026

Early Detection of Acute and Early-Onset Cancer Therapy-Related Cardiac Dysfunction in Children With Cancer Using a Multiparametric Approach: Methodological Aspects of the EARLY StudyTheodorus W Kouwenberg, Heynric B Grotenhuis, Leontien C M Kremer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015

Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood CancerElizabeth A M Feijen, Wendy M Leisenring, Kayla L Stratton, et al.

Journal of Cancer Survivorship : Research and Practice|March 27, 2021

Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic reviewRemy Merkx, Jan M Leerink, Esmée C de Baat, et al.

European Journal of Heart Failure|August 19, 2020

The cancer patient and cardiologyJosé Luis Zamorano, Christer Gottfridsson, Riccardo Asteggiano, et al.

JACC. Cardiooncology|August 16, 2021

Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: <i>JACC CardioOncology</i> State-of-the-Art ReviewJan M Leerink, Esmée C de Baat, Elizabeth A M Feijen, et al.

Pageof 4